Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Return on Sales (2016 - 2025)

Historic Return on Sales for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to 314.32%.

  • BioRestorative Therapies' Return on Sales fell 3045300.0% to 314.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 37.85%, marking a year-over-year decrease of 57900.0%. This contributed to the annual value of 28.82% for FY2024, which is 755800.0% up from last year.
  • Latest data reveals that BioRestorative Therapies reported Return on Sales of 314.32% as of Q3 2025, which was down 3045300.0% from 10.9% recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Return on Sales ranged from a high of 9.79% in Q3 2024 and a low of 1265.38% during Q4 2022
  • In the last 5 years, BioRestorative Therapies' Return on Sales had a median value of 166.87% in 2023 and averaged 286.32%.
  • In the last 5 years, BioRestorative Therapies' Return on Sales plummeted by -8048700bps in 2021 and then surged by 10985000bps in 2023.
  • BioRestorative Therapies' Return on Sales (Quarter) stood at 801.85% in 2021, then plummeted by -58bps to 1265.38% in 2022, then soared by 87bps to 166.87% in 2023, then surged by 63bps to 62.13% in 2024, then crashed by -406bps to 314.32% in 2025.
  • Its Return on Sales was 314.32% in Q3 2025, compared to 10.9% in Q2 2025 and 192.3% in Q1 2025.